The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Doses of Nicotine and Lung Carcinogens Delivered to Cigarette Smokers
Open accessAbstract
BACKGROUND: Cigarette smoke yields of tar and nicotine obtained under the Federal Trade Commission (FTC)-specified machine-smoking protocol (35-mL puff volume drawn for 2 seconds once per minute) may not accurately reflect the delivery of toxins and carcinogens to the smoker. We conducted this study to obtain more realistic estimates of exposure to components of cigarette smoke that affect lung cancer risk. METHODS: We used a pressure transducer system to evaluate puffing characteristics for 133 smokers of cigarettes rated by the FTC at 1.2 mg of nicotine or less (56 smokers of low-yield cigarettes [</=0.8 mg of nicotine per cigarette] and 77 smokers of medium-yield cigarettes [0.9-1.2 mg of nicotine per cigarette]). We programmed measurements from a randomly chosen subset of 72 of these smokers into a piston-type machine to generate smoke from each smoker's usual brand of cigarettes for assays of nicotine, carbon monoxide, tar, and the lung cancer-causing agents 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene. The FTC protocol was also used to assess levels of targeted components in the 11 brands most frequently smoked by study subjects. RESULTS: Compared with the FTC protocol values, smokers of low- and medium-yield brands took in statistically significantly larger puffs (48.6 and 44.1 mL, respectively) at statistically significantly shorter intervals (21.3 and 18.5 seconds, respectively), and they drew larger total smoke volumes than specified in the FTC parameters. They received, respectively, 2.5 and 2.2 times more nicotine and 2.6 and 1.9 times more tar than FTC-derived amounts, as well as about twofold higher levels of benzo[a]pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Smokers of medium-yield cigarettes compared with smokers of low-yield cigarettes received higher doses of all components. CONCLUSIONS: The FTC protocol underestimates nicotine and carcinogen doses to smokers and overestimates the proportional benefit of low-yield cigarettes. Thus, FTC-based nicotine medication doses prescribed/recommended for smoking cessation may need to be reassessed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire
HEATHERTON, T. F., KOZLOWSKI, L. T., FRECKER, R. C., & FAGERSTROM, K. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01879.x · Cited by 10,738 · cited 2×
“†Fagerstro¨m index( 32 ) is a test of nicotine dependence.”
BackgroundMethodInternational Agency for Research on Cancer (IARC)
(2018) · The Grants Register 2018 · doi:10.1007/978-1-349-94186-5_629 · Cited by 2,801
Smoking and Carcinoma of the Lung
Doll, R., & Hill, A. B. (1950) · BMJ · doi:10.1136/bmj.2.4682.739 · Cited by 1,999
WYNDER, E. L. (1950) · Journal of the American Medical Association · doi:10.1001/jama.1950.02910390001001 · Cited by 1,038
THE CHANGING CIGARETTE, 1950-1995
Hoffmann, D. H. (1997) · Journal of Toxicology and Environmental Health · doi:10.1080/009841097160393 · Cited by 815
Wingo, P. A., Ries, L. A. G., Giovino, G. A., Miller, D. S., Rosenberg, H. M., Shopland, D. R., Thun, M. J., & Edwards, B. K. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.8.675 · Cited by 582
Hoffmann, D., Djordjevic, M. V., & Hoffmann, I. (1997) · Preventive Medicine · doi:10.1006/pmed.1997.0183 · Cited by 421
Self-citationNicotine Medications for Smoking Cessation
Henningfield, J. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511023331807 · Cited by 352 · cited 3×
“(Nicotine nasal spray differs from other recently marketed nicotine medications in that nicotine is absorbed rapidly from the nose and produces psychologic effects that resemble effects of an equal dose of inhaled cigarette smoke.) Our observations suggest a need to re-evaluate the doses of nicotine that are recommend…”
BackgroundMethodInfluentialExperimental production of carcinoma with cigarette tar.
Wynder, E. L., GRAHAM, E. A., & Croninger, A. B. (1953) · PubMed · Cited by 338
Hoffmann, D., Brunnemann, K. D., Prokopczyk, B., & Djordjevic, M. V. (1994) · Journal of Toxicology and Environmental Health · doi:10.1080/15287399409531825 · Cited by 330
Self-citationTobacco and tobacco smoke : studies in experimental carcinogenesis
Wynder, E. L., & Hoffmann, D. (1967) · Academic Press eBooks · Cited by 211
Excess mortality among cigarette smokers: changes in a 20-year interval.
Thun, M. J., Day-Lally, C. A., Calle, E. E., Flanders, W. D., & Heath, C. W. (1995) · American Journal of Public Health · doi:10.2105/ajph.85.9.1223 · Cited by 206
Puff volume increases when low-nicotine cigarettes are smoked.
Herning, R. I., Jones, R. T., Bachman, J., & Mines, A. H. (1981) · BMJ · doi:10.1136/bmj.283.6285.187 · Cited by 160
Chemical studies on tobacco smoke
Adams, J., Brunnemann, K. D., & Hoffmann, D. (1983) · Journal of Chromatography A · doi:10.1016/s0021-9673(01)88249-2 · Cited by 152
Patterns of lung cancer risk according to type of cigarette smoked
Lubin, J. H., Blot, W. J., Berrino, F., Flamant, R., Gillis, C. R., Kunze, M., Schmähl, D., & Visco, G. (1984) · International Journal of Cancer · doi:10.1002/ijc.2910330504 · Cited by 152
Benowitz, N. L., Zevin, S., & Jacob, P. (1997) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1997.00566.x · Cited by 107
Wynder, E. L., & Graham, E. A. (1985) · JAMA · doi:10.1001/jama.253.20.2986 · Cited by 89
Nicotine Regulates Smoking Patterns
Djordjevic, M. V., Hoffmann, D., & Hoffmann, I. E. (1997) · Preventive Medicine · doi:10.1006/pmed.1997.0184 · Cited by 84
Self-citationKozlowski, L. T., Rickert, W. S., Pope, M. A., Robinson, J. C., & Frecker, R. C. (1982) · British Journal of Addiction · doi:10.1111/j.1360-0443.1982.tb01417.x · Cited by 84
Impact of Filter Cigarette Smoking on Lung Cancer Histology
Stellman, S. D., Muscat, J. E., Hoffmann, D., & Wynder, E. L. (1997) · Preventive Medicine · doi:10.1006/pmed.1997.0212 · Cited by 75
Self-citationSelf-regulation of smoking intensity. Smoke yields of the low-nicotine, low-‘tar’cigarettes
Djordjevic, M. V., Fan, J., Ferguson, S., & Hoffmann, D. (1995) · Carcinogenesis · doi:10.1093/carcin/16.9.2015 · Cited by 68
Self-citationPrevalence of the misuse of ultra-low-tar cigarettes by blocking filter vents.
Kozlowski, L. T., Pope, M. A., & Lux, J. E. (1988) · American Journal of Public Health · doi:10.2105/ajph.78.6.694 · Cited by 64
Fagerstr�m, K. O. (1982) · Psychopharmacology · doi:10.1007/bf00431941 · Cited by 56
Djordjevic, M. V., Brunnemann, K. D., & Hoffmann, D. (1989) · Carcinogenesis · doi:10.1093/carcin/10.9.1725 · Cited by 47
Self-citationAssessment of major carcinogens and alkaloids in the tobacco and mainstream smoke of ussr cigarettes
Djordjevic, M. V., Sigountos, C. W., Hoffmann, D., et al. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910470306 · Cited by 31
Self-citation
Cited by
On judging the significance of differences by examining the overlap between confidence intervals.
Schenker, N., & Gentleman, J. F. (2001) · The American Statistician · doi:10.1198/000313001317097960 · Cited by 1,218
Alberg, A. J., Brock, M. V., & Samet, J. M. (2016) · Murray and Nadel's Textbook of Respiratory Medicine · doi:10.1016/b978-1-4557-3383-5.00052-x · Cited by 781
The Less Harmful Cigarette: A Controversial Issue. A Tribute to Ernst L. Wynder
Hoffmann, D., Hoffmann, I., & El-Bayoumy, K. (2001) · Chemical Research in Toxicology · doi:10.1021/tx000260u · Cited by 745
Alberg, A. J., Ford, J. G., & Samet, J. M. (2007) · Chest · doi:10.1378/chest.07-1347 · Cited by 626
Nicotine Levels in Electronic Cigarettes
Goniewicz, M. L., Kuma, T., Gawron, M., Knysak, J., & Kosmider, L. (2013) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts103 · Cited by 590
Metadata
- Authors
- Djordjevic, M. V., Stellman, S. D., & Zang, E.
- Venue
- JNCI: Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-01-19
- Volume
- 92
- Issue
- 2
- Pages
- 106-111
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2078519449
- Cited by
- 282
- References
- 25
- FWCI
- 7.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.